Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.04 USD | +0.15% |
|
+7.74% | +210.22% |
03:14pm | Sector Update: Health Care Stocks Steady Premarket Wednesday | MT |
Jul. 09 | Arcutis Biotherapeutics Gets FDA Approval for Atopic Dermatitis Supplemental NDA | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+210.22% | 1.16B | |
+19.44% | 125B | |
+20.01% | 114B | |
+23.84% | 26.73B | |
-23.72% | 19.43B | |
-18.21% | 16.22B | |
-19.87% | 15.33B | |
+8.76% | 14.42B | |
-48.79% | 14.33B | |
+55.81% | 14.2B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Truist Securities Lowers Arcutis Biotherapeutics' Price Target to $45 From $50, Maintains Buy Rating